Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_assertion type Assertion NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_head.
- NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_assertion description "[Taken together, our data demonstrate that downregulation of CXCL16 plays an important role in renal cancer development and progression, and that CXCL16 in RCC is an independent prognostic marker for better patient survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_provenance.
- NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_assertion evidence source_evidence_literature NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_provenance.
- NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_assertion SIO_000772 19070478 NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_provenance.
- NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_assertion wasDerivedFrom befree-20150227 NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_provenance.
- NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_assertion wasGeneratedBy ECO_0000203 NP934132.RA-mYJjC1o3-VyImTLFM_Cte-SF26604z0OKlvsOH5fPA130_provenance.